Endo Biologics Limited

Member Case
Lead case is: 7:22-bk-22549

New York Southern Bankruptcy Court
Chapter 11
Judge:James L Garrity Jr
Case #: 7:23-bk-22414
Case Filed:May 31, 2023
Terminated:Dec 05, 2024

TypeCorporation
Tax IDsubscribers only
Est. Assets$1,000,000,001 to $10 billion
Est. Liabilities $0 to $50,000
Nature of Business Other
Nature of Debts Primarily Business

Debtor
Operand Pharmaceuticals II Limited
1400 Atwater Drive
Malvern, PA 19355
Represented By
Paul D. Leake
Skadden, Arps, Slate, Meagher & Flom LLP
contact info
Last checked: never
U.S. Trustee
United States Trustee
Office of the United States Trustee - NY Alexander Hamilton Custom House One Bowling Green, Room 534
New York, NY 10004


Docket last updated: 37 minutes ago
Thursday, December 05, 2024
11 11 order Order, Final Decree Thu 12/05 2:37 PM
Order signed on 12/5/2024 (I) Closing Certain Chapter 11 Cases; (II) Granting Final Decrees in Certain Closed Chapter 11 Cases: (III) Amending Caption of Remaining Cases: and (IV) Granting Related Relief. (Rodriguez, Willie)
Related: [-]
misc Close Bankruptcy Case Thu 12/05 11:06 PM
Case Closed. (Rodriguez, Willie)
Related: [-]
Tuesday, June 25, 2024
10 10 misc Chapter 11 Monthly Operating Report UST Form 11-MOR Tue 06/25 8:51 PM
Chapter 11 Monthly Operating Report for the Month Ending: 03/31/2024 Filed by Catherine V. LoTempio on behalf of Endo Biologics Limited. (LoTempio, Catherine)
Related: [-]
Monday, July 17, 2023
misc Terminate Pending Deadlines Mon 07/17 5:54 PM
Pending Deadlines Terminated: All Schedules and Statements. (Rodriguez, Willie)
Related: [-]
Friday, July 14, 2023
9 9 misc Statement of Financial Affairs Fri 07/14 4:50 PM
Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle)
Related: [-]
8 8 misc Schedules Fri 07/14 4:48 PM
Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes and Summary and Schedules of Assets and Liabilities for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle)
Related: [-]
Thursday, July 06, 2023
7 7 order Motion, Extend Deadline to File Schedules Thu 07/06 12:40 PM
Order signed on 7/6/2023 Granting Motion To Extend Deadline to File Schedules or Provide Required Information: Deadline: 7/14/2023 Related [+] (Rodriguez, Willie)
Related: [-] 3
misc Set Deficiency Deadlines Thu 07/06 12:29 PM
Deficiencies Set: Schedule A/B due 6/14/2023. Schedule D due 6/14/2023. Schedule E/F due 6/14/2023. Schedule G due 6/14/2023. Schedule H due 6/14/2023. Summary of Assets and Liabilities due 6/14/2023. Statement of Financial Affairs due 6/14/2023. Incomplete Filings due by 6/14/2023, (Porter, Minnie)
Related: [-]
Friday, June 30, 2023
6 6 48 pgs misc Transcript Fri 06/30 4:51 PM
Transcript regarding Hearing Held on 6/22/2023 at 11:09 AM RE: Motion to Extend Deadline to File Schedules or Provide Required Information. Remote electronic access to the transcript is restricted until 9/28/2023. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) Related [+]. Notice of Intent to Request Redaction Deadline Due By 7/7/2023. Statement of Redaction Request Due By 7/21/2023. Redacted Transcript Submission Due By 7/31/2023. Transcript access will be restricted through 9/28/2023. (Ortiz, Carmen)
Related: [-] 3
Tuesday, June 20, 2023
5 5 misc Certificate of No Objection Pursuant to LR 9075-2 Tue 06/20 5:50 PM
Certificate of No Objection Pursuant to LR 9075-2 /Certificate of No Objection to Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle)
Related: [-]
Friday, June 16, 2023
4 4 misc Disclosure of Compensation of Attorney For Debtor (Rule 2016(b)) - Form 2030 Fri 06/16 5:07 PM
Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Lisa Laukitis on behalf of Operand Pharmaceuticals II Limited. (Laukitis, Lisa)
Related: [-]
Thursday, June 08, 2023
misc Case Association - Joint Administration Thu 06/08 10:05 AM
Case Jointly Administrated with Case # 22-22549 per Order signed on 8/17/2023 in Case # 22-22549 Doc # 45. (Rodriguez, Willie)
Related: [-]
misc Add Claims and Noticing Agent Thu 06/08 10:10 AM
Claims and Noticing Agent, Kroll Restructuring Administration LLC, added to the case. (Rodriguez, Willie)
Related: [-]
Monday, June 05, 2023
3 3 motion Motion, Extend Deadline to File Schedules Mon 06/05 8:03 PM
Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: 6/22/2023 at 11:00 AM, Objection Deadline: 6/15/2023 at 4:00 PM) Notice of Hearing and Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors (Attachment: Ex. A: Proposed Order) filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited with hearing to be held on 6/22/2023 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 6/15/2023,. (Ortiz, Kyle)
Related: [-]
Thursday, June 01, 2023
misc Add Judge Thu 06/01 7:59 AM
Judge James L. Garrity, Jr. added to the case. (Porter, Minnie)
Related: [-]
Wednesday, May 31, 2023
2 2 7 pgs answer Statement Wed 05/31 7:41 PM
Statement / Notice of Commencement of Chapter 11 Cases and Joint Administration filed by Paul D. Leake on behalf of Operand Pharmaceuticals II Limited. (Leake, Paul)
Related: [-]
1 1 22 pgs misc Voluntary Petition (Chapter 11) Wed 05/31 7:14 PM
Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Case Designated As Mega as per LBR 1073-1. Filed by Paul D. Leake of Skadden, Arps, Slate, Meagher & Flom LLP on behalf of Operand Pharmaceuticals II Limited. (Leake, Paul)
Related: [-]
crditcrd Auto - docket of credit card Wed 05/31 7:29 PM
Receipt of Voluntary Petition (Chapter 11)([LINK 23-22414 ) [misc,824] (1738.00) Filing Fee. Receipt number A16224215. Fee amount 1738.00. Related [+] (U.S. Treasury)
Related: [-] Doc #1